Rivaroxaban

Supplier: CAYMAN

16043-10 16043-1 16043-50 16043-5
CAYM16043-10EA 193 EUR
CAYM16043-10 CAYM16043-1 CAYM16043-50 CAYM16043-5
Rivaroxaban
Rivaroxaban

Rivaroxaban is an orally active, direct inhibitor of Factor Xa (Ki = 0,4 nm), which is a crucial component of the intrinsic and extrinsic pathways of the blood coagulation cascade.


  • Purity: ≥98%


It demonstrates >10 000-fold greater selectivity for Factor Xa compared to other related serine proteases. In various animal arterial and venous thrombosis models, rivaroxaban is reported to inhibit thrombin formation without prolonging bleeding time and has been approved for clinical use as an anticoagulant in the prevention of stroke and the treatment of venous thromboembolisms.

Formula: C₁₉H₁₈ClN₃O₅S
MW: 435.89 g/mol
MDL Number: MFCD11974010
CAS Number: 366789-02-8

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR